bioSyntagma
Predictive analytics and biomarker discovery for treating cancer
David Richardson - Co-Founder and CEO, Dmitry Derkach MD, PhD - Chief Science Officer, Colleen Ziegler - Co-Founder, Director of Operations
1-10 employees
$1,200,000 funding, Other
2015
